Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed obesity and diabetes treatments.
- GLP-1RAs may also have beneficial effects on various other health conditions.
- The potential broader health effects of GLP-1RAs warrant further examination.
- Current evidence supports their significant role in managing weight and blood sugar levels.
Simplified